1 May 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
1 May 2024 - NICE has published updated evidence-based recommendations on the pembrolizumab (Keytruda) for the treatment of patients with ...
25 April 2024 - NICE is unable to make a recommendation on the use of melphalan flufenamide hydrochloride (Pepaxti) in combination ...
24 April 2024 - A new targeted drug combination treatment, described as a ‘step-change in care’ for children and young ...
24 April 2024 - NICE is unable to make a recommendation on the use of pembrolizumab (Keytruda) in combination with cisplatin ...
11 April 2024 - Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia. ...
10 April 2024 - NICE has published final evidence-based recommendations on the use of cabozantinib maleate (Cabometyx) in combination with ...
3 April 2024 - NICE has published final evidence-based recommendations on the use of dostarlimab (Jemperli) in combination with platinum-based ...
28 February 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
6 March 2024 - NICE has published final evidence-based recommendations on the use of epcoritamab (Tepkinly) for the treatment of ...
6 March 2024 - NICE has published final draft guidance that does not recommend Enhertu (trastuzumab deruxtecan; Daiichi Sankyo) for treating ...
5 March 2024 - A new treatment option given with chemotherapy is recommended for some types of advanced or recurrent ...
21 February 2024 - NICE has published final evidence-based recommendations on the use of talazoparib tosylate (Talzenna) for the treatment ...
9 February 2024 - NICE is reviewing its guidance on the use of isatuximab for the treatment of patients with ...
7 February 2024 - NICE has published final evidence-based recommendations on the use of nivolumab with relatlimab (Opdualag) for the ...